Related Experiment Video
Updated: Jun 14, 2026
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
The cellular and developmental biology of medulloblastoma: current perspectives on experimental therapeutics
Vinit Krishna Srivastava1, Josephine Nalbantoglu
1Department of Neurology & Neurosurgery, McGill University and Montreal Neurological Institute, Montreal, Canada.
Abstract:
Dysregulation of various signaling pathways that govern cerebellar development with respect to cell proliferation, growth arrest, apoptosis and differentiation has been postulated to contribute to medulloblastoma tumourigenesis. This review will highlight the unique nature of cerebellar development in terms of its derivation from two germinal matrices and significant postnatal expansion of the granule cell precursor (GCP) compartment resulting in granule cell development and migration to form the mature cerebellar cortex. The molecular signals that are critical for timely cell cycle exit and differentiation may become dysregulated leading to unrestrained cell proliferation and enhanced cell survival; indeed, changes in these molecular markers have been observed in medulloblastoma biopsy specimens. Furthermore, transgenic models that faithfully replicate these changes develop medulloblastoma that, by in large, recapitulates the clinico-histopathological features of these tumours. Cellular and developmental biological approaches have contributed greatly to the current debate on the relevance of the cancer stem cell hypothesis in understanding medulloblastoma initiation and propagation. Penultimately, research findings are being translated into experimental therapeutics that target the aberrant signal transduction machinery in medulloblastoma cells and that will hopefully lead to an improved risk-benefit profile.
Insights
Medulloblastoma arises from disrupted cerebellar development signaling pathways. Understanding these pathways in granule cell precursors (GCPs) aids in developing targeted therapies for this brain tumor.
Area of Science:
- Neuroscience
- Developmental Biology
- Oncology
Background:
- Medulloblastoma (MB) tumorigenesis is linked to dysregulated signaling pathways controlling cerebellar development.
- The cerebellum's unique dual germinal matrix origin and postnatal granule cell precursor (GCP) expansion are critical developmental features.
Purpose of the Study:
- To review the unique aspects of cerebellar development and their role in medulloblastoma.
- To explore how dysregulated molecular signals in GCPs contribute to MB initiation and progression.
- To discuss the relevance of cancer stem cell hypotheses and emerging therapeutic strategies for MB.
Main Methods:
- Review of existing literature on cerebellar development and medulloblastoma.
- Analysis of molecular signaling pathways involved in GCP proliferation, differentiation, and apoptosis.
- Examination of transgenic models that mimic MB development.
- Discussion of cellular and developmental biology approaches to MB.
Main Results:
- Aberrant molecular signals governing cell cycle exit and differentiation in GCPs lead to uncontrolled proliferation and survival, contributing to MB.
- Medulloblastoma biopsy specimens show alterations in these critical molecular markers.
- Transgenic models recapitulate key clinico-histopathological features of human medulloblastoma.
Conclusions:
- Dysregulation of cerebellar developmental pathways is central to medulloblastoma formation.
- Cancer stem cell concepts are relevant to understanding MB initiation and propagation.
- Targeting aberrant signal transduction pathways offers a promising therapeutic avenue for improved medulloblastoma treatment.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
02:56Treatment Resistent Cancers